Cell Reports MedicineCancer BiologyPeer-reviewed journal article
Coordinated protein modules define DNA damage responses to carboplatin at single cell resolution in human ovarian carcinoma models
Jacob S. BediaiD, Antonio Delgado‐GonzáleziD, Ying-Wen HuangiD, Veronica D. GonzaleziD, Ionut-Gabriel FuninganaiD, Zainab Rahil, Alyssa Mike, Alexis J. LowberiD, Maria ViasiD, Alan AshworthiD, James D. BrentoniD, Wendy J. FantliD
Abstract
Tubo-ovarian high-grade serous carcinoma (HGSC) is the most lethal gynecological malignancy and frequently responds to platinum-based chemotherapy because of common genetic and somatic impairment of DNA damage repair (DDR) pathways. The mechanisms of clinical platinum resistance are diverse and poorly molecularly defined. Consequently, there are no biomarkers or medicines that improve patient outcomes. Herein we use single cell mass cytometry (CyTOF) to systematically evaluate the phosphorylation and abundance of proteins known to participate in the DNA damage response (DDR). Single cell analyses of highly characterized HGSC cell lines that phenocopy human patients show that cells with comparable levels of intranuclear platinum, a proxy for carboplatin uptake, undergo different cell fates. Unsupervised analyses revealed a continuum of DDR responses. Decompositional methods were used to identify eight distinct protein modules of carboplatin resistance and sensitivity at single cell resolution. CyTOF profiling of primary and secondary platinum-resistance patient models shows that a complex DDR sensitivity module is strongly associated with response, suggesting it as a potential tool to clinically characterize complex drug resistance phenotypes.
- organism: human
- assay: flow cytometry
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 2
- FWCI
- 1.51
- Field percentile
- top 18%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-Cell Transcriptomic Signatures Enable Stratified Combination Therapy for Platinum-Resistant Ovarian Cancer
Laura Gall-Mas, Katrin Kleinmanns, … Benno Schwikowski·bioRxiv·Mar 6, 2026
- Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
A. T. Wenzel, D. Champa, … O. Harismendy·bioRxiv·Feb 7, 2021
- Protein Expression Patterns in ovarian cancer cells Associated with Monofunctional Platinums Treatment
L. Arzuman, M. A. Moni, … F. Huq·bioRxiv·May 7, 2019
- Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models
Kristin M. Adams, Jae-Rim Wendt, … Jessica D. Lang·Cancer Gene TherapyPeer-reviewed·Jul 19, 2025
- Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms
Elena Lomonosova, Megan Loeb, … Mary Margaret Mullen·bioRxiv·Aug 4, 2025
- Organoid-based modeling of platinum resistance identifies KRT17 as both a response mediator and biomarker for targeted therapy in ovarian cancer
Juliane Reichenbach, Juliana Schmid, … Mirjana Kessler·bioRxiv·Mar 10, 2025